Ki Summary BindingDB logo
myBDB logout
Reaction Details
Report a problem with these data
TargetSomatostatin receptor type 3
LigandBDBM50091505
Substrate/Competitorn/a
Meas. Tech.ChEMBL_1498161 (CHEMBL3583381)
IC50 1.4±n/a nM
Citation Shah, SKHe, SGuo, LTruong, QQi, HDu, WLai, ZLiu, JJian, THong, QDobbelaar, PYe, ZSherer, EFeng, ZYu, YWong, FSamuel, KMadiera, MKaranam, BVReddy, VBMitelman, STong, SXChicchi, GGTsao, KLTrusca, DFeng, YWu, MShao, QTrujillo, MEEiermann, GJLi, CPachanski, MFernandez, GNelson, DBunting, PMorissette, PVolksdorf, SKerr, JZhang, BBHoward, ADZhou, YPPasternak, ANargund, RPHagmann, WK Discovery of MK-1421, a Potent, Selective sstr3 Antagonist, as a Development Candidate for Type 2 Diabetes. ACS Med Chem Lett6:513-7 (2015) [PubMed]  Article
More Info.:Get all data from this article,  Assay Method
 
Somatostatin receptor type 3
Name:Somatostatin receptor type 3
Synonyms:SOMATOSTATIN SST3 | SS-3-R | SS3-R | SS3R | SSR-28 | SSR3_HUMAN | SSTR3 | Somatostatin receptor type 3 (SSTR3)
Type:Protein
Mol. Mass.:45855.97
Organism:Homo sapiens (Human)
Description:P32745
Residue:418
Sequence:
MDMLHPSSVSTTSEPENASSAWPPDATLGNVSAGPSPAGLAVSGVLIPLVYLVVCVVGLL
GNSLVIYVVLRHTASPSVTNVYILNLALADELFMLGLPFLAAQNALSYWPFGSLMCRLVM
AVDGINQFTSIFCLTVMSVDRYLAVVHPTRSARWRTAPVARTVSAAVWVASAVVVLPVVV
FSGVPRGMSTCHMQWPEPAAAWRAGFIIYTAALGFFGPLLVICLCYLLIVVKVRSAGRRV
WAPSCQRRRRSERRVTRMVVAVVALFVLCWMPFYVLNIVNVVCPLPEEPAFFGLYFLVVA
LPYANSCANPILYGFLSYRFKQGFRRVLLRPSRRVRSQEPTVGPPEKTEEEDEEEEDGEE
SREGGKGKEMNGRVSQITQPGTSGQERPPSRVASKEQQLLPQEASTGEKSSTMRISYL
Blast this sequence in BindingDB or PDB
  Blast E-value cutoff:
BDBM50091505
n/a
NameBDBM50091505
Synonyms:CHEMBL3582341
TypeSmall organic molecule
Emp. Form.C30H28FN9O2
Mol. Mass.565.6008
SMILESCCn1cc(cn1)[C@]1(N[C@H](Cc2c1[nH]c1ccccc21)c1nc(c[nH]1)-c1ccc(F)cn1)c1nn(CC2CC2)c(=O)o1 |r|
Structure
Search PDB for entries with ligand similarity:Similarity to this molecule at least: